Related Experiment Video
Updated: Aug 12, 2026

10:01
Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Published on: March 16, 2018
Mycobactin-mediated iron acquisition within macrophages
Minkui Luo1, Evgeny A Fadeev, John T Groves
1Department of Chemistry, Princeton University, Princeton, New Jersey 08544, USA.
Nature Chemical Biology
|January 13, 2006
Summary
Mycobacterium tuberculosis uses lipophilic mycobactins to extract iron from macrophages. This novel pathway involves lipid droplets and could be a new target for controlling tuberculosis infection.
Area of Science:
- Microbiology
- Cell Biology
- Infectious Diseases
Background:
- Iron restriction is crucial for combating bacterial infections.
- Mycobacterium tuberculosis (M. tuberculosis) resides in macrophage phagosomes, facing challenges in iron acquisition.
- In vivo iron acquisition mechanisms of M. tuberculosis remain largely uncharacterized.
Purpose of the Study:
- To investigate the in vivo iron acquisition pathways employed by M. tuberculosis.
- To elucidate the role of mycobactins in intracellular iron extraction from macrophages.
Main Methods:
- Characterization of mycobactin's interaction with macrophage membranes.
- Tracking the localization of mycobactin-iron complexes within macrophages.
- Assessing the proximity of mycobactin-targeted lipid droplets to phagosomes.
Main Results:
- Mycobactins, lipophilic siderophores, efficiently extract intracellular iron from macrophages.
- Mycobactin-iron complexes selectively accumulate in macrophage lipid droplets.
- These lipid droplets containing iron are found in direct contact with M. tuberculosis-containing phagosomes.
Conclusions:
- M. tuberculosis utilizes a novel iron acquisition pathway involving mycobactins and macrophage lipid droplets.
- This pathway exploits host cell mechanisms for iron mobilization and sorting.
- This newly identified pathway presents a potential therapeutic target for controlling mycobacterial infections.
Related Concept Videos
Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

